Gossamer Bio (GOSS) News Today $3.18 -0.28 (-8.09%) Closing price 04:00 PM EasternExtended Trading$3.19 +0.01 (+0.31%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GOSS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Gossamer Bio (GOSS): Assessing Valuation After Encouraging Phase 2 Data and Analyst OptimismSeptember 15 at 9:10 AM | finance.yahoo.comGossamer Bio, Inc. (NASDAQ:GOSS) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 15 at 5:03 AM | americanbankingnews.comAcadian Asset Management LLC Purchases 1,253,353 Shares of Gossamer Bio, Inc. $GOSSSeptember 15 at 4:38 AM | marketbeat.comGossamer Bio (NASDAQ:GOSS) Raised to "Hold" at Wall Street ZenSeptember 15 at 3:43 AM | americanbankingnews.comGossamer Bio (NASDAQ:GOSS) Stock Rating Upgraded by Wall Street ZenSeptember 15 at 2:48 AM | marketbeat.comGossamer Bio (NASDAQ:GOSS) Shares Up 9% - What's Next?September 13 at 5:09 PM | marketbeat.comGossamer Bio (GOSS) Is Up 17.7% After Seralutinib Gains Key FDA Support and Clinical ProgressSeptember 13 at 1:09 PM | finance.yahoo.comGossamer Bio's (GOSS) Overweight Rating Reaffirmed at Cantor FitzgeraldSeptember 13 at 8:51 AM | marketbeat.comGossamer Bio, Inc. $GOSS Shares Sold by Siren L.L.C.September 13 at 6:11 AM | marketbeat.comGossamer Bio's (GOSS) Overweight Rating Reiterated at Cantor FitzgeraldSeptember 13 at 3:27 AM | americanbankingnews.comPiper Sandler Reaffirms Their Buy Rating on Gossamer Bio (GOSS)September 12 at 4:51 PM | theglobeandmail.comH.C. Wainwright Asserts Buy Stance on Gossamer Bio Inc. (GOSS) on Pulmonary Arterial Hypertension Drug ProspectsSeptember 12 at 4:51 PM | finance.yahoo.comGossamer Bio (NASDAQ:GOSS) Shares Gap Up - Time to Buy?September 12 at 1:20 PM | marketbeat.comGossamer Bio Sees Unusually High Options Volume (NASDAQ:GOSS)September 12 at 10:44 AM | marketbeat.comGossamer Bio, Inc. (NASDAQ:GOSS) Given Consensus Rating of "Buy" by AnalystsSeptember 12 at 8:58 AM | marketbeat.comTraders Buy Large Volume of Call Options on Gossamer Bio (NASDAQ:GOSS)September 12 at 2:19 AM | americanbankingnews.comCantor says has reinforced conviction on Gossamer Bio ahead of data readoutSeptember 11, 2025 | msn.comPiper Sandler Reiterates Buy as Seralutinib Momentum Boosts Gossamer (GOSS) Multibagger CaseSeptember 11, 2025 | finance.yahoo.comGossamer Bio (NASDAQ:GOSS) Sets New 12-Month High - Here's WhySeptember 11, 2025 | marketbeat.comGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)September 10, 2025 | businesswire.comGossamer Bio upgraded to Buy from Neutral at UBSSeptember 10, 2025 | msn.comUBS Upgrades Gossamer Bio (GOSS)September 10, 2025 | msn.comGossamer Bio (NASDAQ:GOSS) Shares Down 6% - Time to Sell?September 10, 2025 | marketbeat.comGossamer Bio: Bullish Ahead Of Seralutinib's Phase 3 ReadoutSeptember 9, 2025 | seekingalpha.comAlyeska Investment Group L.P. Sells 4,644,780 Shares of Gossamer Bio, Inc. $GOSSSeptember 8, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Buys New Position in Gossamer Bio, Inc. $GOSSSeptember 6, 2025 | marketbeat.comADAR1 Capital Management LLC Sells 8,088,283 Shares of Gossamer Bio, Inc. $GOSSSeptember 5, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Reaches New 12-Month High - What's Next?September 5, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Stock Price Up 7.9% - Time to Buy?September 4, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Lowers Stake in Gossamer Bio, Inc. $GOSSSeptember 3, 2025 | marketbeat.comGossamer Bio, Inc. $GOSS Shares Sold by DAFNA Capital Management LLCSeptember 1, 2025 | marketbeat.comSiren L.L.C. Cuts Stake in Gossamer Bio, Inc. $GOSSAugust 31, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Hits New 1-Year High - Here's WhyAugust 30, 2025 | marketbeat.comGossamer Bio to Present at Upcoming Investor ConferencesAugust 29, 2025 | businesswire.comGossamer Bio: A Critical Year AheadAugust 28, 2025 | seekingalpha.comH.C. Wainwright and Leerink Partners Reiterate ‘Buy’ Ratings on Gossamer Bio, Inc. (GOSS)August 19, 2025 | finance.yahoo.comAnalysts' Revenue Estimates For Gossamer Bio, Inc. (NASDAQ:GOSS) Are Surging HigherAugust 15, 2025 | finance.yahoo.comGossamer Bio Reports Q2 2025 Financial ResultsAugust 12, 2025 | msn.comInstitutional investors in Gossamer Bio, Inc. (NASDAQ:GOSS) see US$54m decrease in market cap last week, although long-term gains have benefitted them.August 11, 2025 | finance.yahoo.comQ3 EPS Estimates for Gossamer Bio Increased by HC WainwrightAugust 11, 2025 | marketbeat.comWedbush Has Optimistic Outlook of Gossamer Bio Q3 EarningsAugust 11, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Stock Rating Lowered by Wall Street ZenAugust 10, 2025 | marketbeat.comLeerink Partners Sticks to Its Buy Rating for Gossamer Bio (GOSS)August 9, 2025 | theglobeandmail.comQ3 EPS Estimates for Gossamer Bio Reduced by Leerink PartnrsAugust 9, 2025 | marketbeat.comGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 7, 2025 | businesswire.comWedbush Boosts Gossamer Bio (NASDAQ:GOSS) Price Target to $5.00August 7, 2025 | marketbeat.comFY2025 EPS Estimates for Gossamer Bio Boosted by AnalystAugust 7, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Issues Earnings Results, Beats Expectations By $0.01 EPSAugust 6, 2025 | marketbeat.comGossamer Bio (GOSS) Expected to Announce Quarterly Earnings on MondayAugust 5, 2025 | marketbeat.comGossamer Bio, Inc. (NASDAQ:GOSS) Shares Sold by GSA Capital Partners LLPAugust 3, 2025 | marketbeat.com Get Gossamer Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GOSS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GOSS Media Mentions By Week GOSS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GOSS News Sentiment▼0.520.94▲Average Medical News Sentiment GOSS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GOSS Articles This Week▼273▲GOSS Articles Average Week Get the Latest News and Ratings for GOSS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Gossamer Bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CNTA News Today TARS News Today MLYS News Today IBRX News Today DNLI News Today OCUL News Today IRON News Today BLTE News Today AGIO News Today ARQT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GOSS) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gossamer Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gossamer Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
